title: Evidence that pulmonary vascular pathology explains the decline in lung function associated with interferon α based therapies for chronic hepatitis C virus.
authors.forename: Peter M
authors.initials: PM
authors.lastname: George
authors.forename: Jane A
authors.initials: JA
authors.lastname: Mitchell
mesh_terms: D000418:Albumins / Q000009:adverse effects*; D000998:Antiviral Agents / Q000009:adverse effects*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008168:Lung / Q000187:drug effects*; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D008297:Male; D011092:Polyethylene Glycols / Q000009:adverse effects*; D012254:Ribavirin / Q000009:adverse effects*
chemical_list: D000418:Albumins; D000998:Antiviral Agents; D016898:Interferon-alpha; D011092:Polyethylene Glycols; D012254:Ribavirin